NYSE:PENMedical Equipment
Penumbra (NYSE:PEN) Shares Surge 26% After US$1.2B Sales Growth
Penumbra (NYSE:PEN) reported strong sales growth for 2024 with total sales of $1,195 million, up from $1,059 million in the prior year, although net income dropped significantly from $91 million to $14 million. Earnings per share also saw a decrease. Despite this mixed performance, the company's share price surged 26% over the last quarter. This increase might be attributed to positive corporate guidance, where Penumbra projected revenue growth of 12% to 14% for 2025. During the same period,...